Post by
craighenry on Dec 27, 2022 5:44pm
This shows how the Financing Market is out there
For many Biotech alike. Bioasis is no different.
"Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics"
This for Jounce shareholders is almost criminal.
Yes, before the resident but job mouths off, I know this has nothing to do with Bioasis.
My point is that DR probably had no other option other than to file C11.
There is not this big "conspiracy" that the nut job wants you to believe.
Link to the Gilead deal below:
https://www.stockwatch.com/News/Item/U-b20221227005077-U!JNCE-20221227/U/JNCE
Comment by
craighenry on Dec 27, 2022 6:12pm
"Money could be found" yeah!! Good one JD. How many failed financings did DR attempt? Lolololol What a clown
Comment by
Boomskid on Dec 27, 2022 6:23pm
craig asked, "How many failed financings did DR attempt?" How many do you remember, craig? Maybe I'm getting too old to remember all the financings she's attempted. JD
Comment by
craighenry on Dec 27, 2022 6:29pm
I believe there were two that were mentioned/ tossed around. I also remember we spoke about potential financings when we were on a call with her. And she explained the difficulty of raising cash at that point in time. Get help psycho
Comment by
craighenry on Dec 27, 2022 7:10pm
Resident Nut Job - you obviously dont remember the PP for 5 million (give or take a few) that could NOT be filled. You know.... the PP that your buddy crispi bought into. Well, because you and crispi were the only ones that could "read between the lines" LMFAO!!!!!!!!
Comment by
emmitfitzhume on Dec 27, 2022 8:40pm
I was under the impression there were some interested investor(s) earlier in the year but that the proposed investment could not or did not pass muster with the TSX. I have no other specifics on this but certainly any other financing would have been better than what we are currently faced with from a shareholder standpoint.
Comment by
craighenry on Dec 27, 2022 6:20pm
For those of you familiar with Jounce..... with this deal Jounce left about 700 million dollars in potential milestone payments on the table. Very sad.